Ikeda, Yuki
Inomata, Takayuki
Kida, Keisuke
Shibagaki, Yugo
Sato, Naoki
Izumi, Tohru
Ako, Junya
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR
https://doi.org/10.1007/s00380-018-1270-x
Article History
Received: 9 May 2018
Accepted: 21 September 2018
First Online: 26 September 2018
Compliance with ethical standards
:
: Dr. Takayuki Inomata received lecture honoraria from Otsuka Pharmaceutical Co. and Daiichi-Sankyo Pharmaceutical. Dr. Yugo Shibagaki received lecture honoraria from Otsuka Pharmaceutical and Novartis Pharma; and research funding from Otsuka Pharmaceutical, Teijin Pharma and Kyowa-Hakko Kirin. Dr. Naoki Sato received consultancy fees from Novartis and Terumo; lecture honoraria from Otsuka, Daiichi-Sankyo, Ono, Eisai, Bayer, Boehringer-Ingelheim, Roche Diagnostics-Japan, Astellas, and Teijin; and research supports to institution from Roche-Japan and Astellas. The other authors have nothing to disclose.